Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Biasoni, Valentina ^a   Patriarca, Ambra ^a   Dalmasso, Paola ^a   Bertagna, Angela ^a   Manieri, Chiara ^a   Benedetto, Chiara ^a   Revelli, Alberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; GONADOTROPIN; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN; FOLLITROPIN;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; OVARIAN FUNCTION TEST; OVARIAN SENSITIVITY INDEX; OVARY FOLLICLE; BLOOD; DRUG EFFECT; METHODOLOGY; OOCYTE RETRIEVAL; OVARY; OVULATION INDUCTION; PHYSIOLOGY;

ADULT; ANTI-MULLERIAN HORMONE; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; OOCYTE RETRIEVAL; OVARY; OVULATION INDUCTION;

EID: 79961156972     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-112     Document Type: Article

References (14)

1. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006, 12:685-718. 10.1093/humupd/dml034, 16891297.
2. de Carvalho BR, Rosa e Silva AC, Rosa e Silva JC, dos Reis RM, Ferriani RA, Silva de Sá MF. Ovarian reserve evaluation: state of the art. J Assist Reprod Genet 2008, 25:311-322. 10.1007/s10815-008-9241-2, 2596675, 18679790.
3. Al-Azemi M, Killick SR, Duffy S, Pye C, Refaat B, Hill N, Ledger W. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction. Hum Reprod 2011, 26:414-422. 10.1093/humrep/deq339, 21147822.
4. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010, 16:113-130. 10.1093/humupd/dmp036, 19793843.
5. Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 2009, 91:705-714. 10.1016/j.fertnstert.2007.12.013, 18321493.
6. La Marca A, Nelson SM, Sighinolfi G, Manno M, Baraldi E, Roli L, Xella S, Marsella T, Tagliasacchi D, D'Amico R, Volpe A. Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction. Reprod Biomed Online 2011, 22:341-349. 10.1016/j.rbmo.2010.11.005, 21317041.
7. Ledger WL. Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology. J Clin Endocrinol Metab 2010, 95:5144-5154. 10.1210/jc.2010-0701, 21131535.
8. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004, 10:77-83. 10.1093/molehr/gah015, 14742691.
9. Fanchin R, Schonäuer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003, 18:323-327. 10.1093/humrep/deg042, 12571168.
10. Jayaprakasan K, Deb S, Batcha M, Hopkisson J, Johnson I, Campbell B, Raine-Fenning N. The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Müllerian hormone and response to controlled ovarian stimulation. Fertil Steril 2010, 94:1775-1781. 10.1016/j.fertnstert.2009.10.022, 19931077.
11. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006, 91:4057-4063. 10.1210/jc.2006-0331, 16804046.
12. Streuli I, Fraisse T, Chapron C, Bijaoui G, Bischof P, de Ziegler D. Clinical uses of anti-Müllerian hormone assays: pitfalls and promises. Fertil Steril 2009, 91:226-230. 10.1016/j.fertnstert.2007.10.067, 18249391.
13. Saldeen P, Källen K, Sundström P. The probability of successful IVF outcome after poor ovarian response. Acta Obstet Gynecol Scand 2007, 86:457-461. 10.1080/00016340701194948, 17486468.
14. Lehert P, Schertz JC, Ezcurra D. Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis. Reprod Biol Endocrinol 2010, 8:112-125. 10.1186/1477-7827-8-112, 2954883, 20846363.